Immunotherapy with Chemotherapy Effective for HPV-Negative Head and Neck Cancer
Source: Inside Precision Medicine
The study evaluated a novel treatment regimen that combines nivolumab with chemotherapy followed by response-adaptive chemo-radiation therapy.
A new clinical trial exploring a combination of chemotherapy and immunotherapy shows promising results for patients with advanced human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). The Phase II, nonrandomized study, le… [3584 chars]